Pharmaceutical packaging can induce confusion

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7338.679/a (Published 16 March 2002) Cite this as: BMJ 2002;324:679
  1. Michael Rigby (m.j.rigby@keele.ac.uk), senior lecturer
  1. Centre for Health Planning and Management, Keele University, Keele, Staffordshire ST5 5BG

    EDITOR—The pharmaceutical industry seems to be dominated by packaging initiatives that unnecessarily compromise patient compliance and thus safety. A middle aged male patient in Ireland reports the challenge he faces daily as a result of inventiveness in product presentation. Currently he is prescribed six not unusual medications for a hypertensive condition and related effects, one replacing a previous drug. The packaging of each is in blister packs, one tablet to be taken per day, but the total non-standardisation of presentation is shown in the table.

    View this table:

    Packaging of seven commonly prescribed drugs for one patient

    The …

    View Full Text

    Sign in

    Log in through your institution